AYVAKYT 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Blueprint Medicines (Netherlands) B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d9c0d6a896f3d704
Drug Cima Aemps Name: AYVAKYT 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1201473003
Holder Company Name: Blueprint Medicines (Netherlands) B.V.
Marketing Company Name: Blueprint Medicines (Netherlands) B.V.
Holder Company Detail Path: /organization/blueprint-medicines-netherlands-bv
Marketing Company Detail Path: /organization/blueprint-medicines-netherlands-bv
Authorization Date: 2022-05-26
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 300 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Blueprint Medicines (Netherlands) B.V.
Company Detail Path: /organization/blueprint-medicines-netherlands-bv

AVAPRITINIB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 26, 2022

Approval ID

d9c0d6a896f3d704

Type

Standard